Vascular Disease, Alzheimer's Disease, and Mild Cognitive Impairment
Advancing an Integrated Approach
- Publisher's listprice GBP 96.00
-
43 344 Ft (41 280 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 4 334 Ft off)
- Discounted price 39 010 Ft (37 152 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
43 344 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 22 April 2020
- ISBN 9780190634230
- Binding Hardback
- No. of pages504 pages
- Size 239x160x35 mm
- Weight 839 g
- Language English 0
Categories
Short description:
The focus of this edited volume is to examine how Alzheimer's disease and vascular dementia, as well as their mild cognitive impairment analogs, are best viewed as a heterogeneous, intersecting, if not a continuous disease state rather than separate, distinct entities. This book examines this approach by providing empirically based evidence, reviews of the literature, and chapters by key leaders in the field and will be of interest to clinical neuropsychologists and anyone studying or treating dementia in its many forms.
MoreLong description:
Alzheimer's disease (AD) and vascular dementia (VaD) are commonly viewed as the first and second most common types of dementia, respectively. The traditional paradigm has been to view and treat each illness as a separate entity with a separate pathophysiology. However, clinical and pathological studies suggest that the boundary separating AD and VaD, as well as their mild cognitive impairment (MCI) analogs, is not well defined. Thus, there is increased interest in viewing these diseases along a spectrum because of the significant overlap in the characterization and diagnosis of AD, VaD, and MCI. The focus of this edited volume is to examine how AD and VaD, as well as their MCI analogs, are best viewed as a heterogeneous, intersecting, if not a continuous disease state rather than separate, distinct entities. This book examines this approach by providing empirically based evidence, reviews of the literature, and chapters by key leaders in the field and will be of interest to clinical neuropsychologists and anyone studying or treating dementia in its many forms.
A 'must-read,' very timely, comprehensive interdisciplinary overview illuminating the complexity of the dementia syndromes, particularly Vascular-Alzheimer spectrum disorders."
-Sandra E. Black, Professor of Medicine (Neurology), Department of Medicine, Sunnybrook HSC and University of Toronto
Table of Contents:
Preface
Part 1: Epidemiology and Neuropsychology
Chapter 1: Vascular risk factors and their relationship to brain aging: Findings from the Framingham Heart Study
Chapter 2: Neuropsychological Profiles in Alzheimer's/ Vascular Spectrum Dementia
Chapter 3: Neuropsychological Diagnostic Criteria for Mild Cognitive Impairment due to Alzheimer's Disease
Chapter 4: Vascular Cognitive Impairment
Chapter 5: Decline in Everyday Functioning in MCI and Dementia: A Neuropsychological Perspective
Chapter 6: Heterogeneity in Dementia and MCI: Using Statistical Modeling Techniques
Chapter 7: Apraxic and Action-Intentional Disorders Associated With Vascular And Degenerative Dementing Diseases
Part 2: Neuroimaging
Chapter 8: Cerebral small vessel disease and the risk of dementia and cognition decline
Chapter 9: Structural MRI in Alzheimer's disease: Are we measuring the right stuff
Chapter 10: Advances in Multi-Modal Imaging Across the Spectrum of Normal to Pathological aging: Incorporating Vascular Comorbidities Common to Alzheimer's disease and Vascular Dementia
Part 3: Blood-Brain-Barrier and Cardiogenic Mechanisms
Chapter 11: The Blood-Brain Barrier in Cognitive Decline and Alzheimer's Disease
Chapter 12: Arterial Stiffening and Cerebrovascular Resistance in Cognitive Decline and Alzheimer's Disease
Chapter 13: Hemodynamics in Alzheimer's Disease and Vascular Cognitive Impairment & Dementia
Part 4: Neuropathological and Neurophysiological Mechanisms
Chapter 14: Neuropathology of AD/ VaD Dementia
Chapter 15: Potential of blood- and CSF-based biomarkers for AD diagnostics
Chapter 16: Unravelling the Role of Mitochondria in Alzheimer's disease: Toward Assembling the Puzzle
Part 5: Treatment and Intervention
Chapter 17: Dementia and Elective Surgeries: Considerations for Neuropsychologists
Chapter 18: Management of Mild Cognitive Impairment
